Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2021 Who Should Implement Force When It’s Needed and How Should It Be Done Compassionately? Matthew Lin, MD Covert medication administration might be as forceful as physical or chemical restraint for patients lacking insight. AMA J Ethics. 2021;23(4):E311-317. doi: 10.1001/amajethics.2021.311. Case and Commentary May 2021 Should Needlestick Protocols Influence Documentation or Disclosure of a Patient’s HIV Status? Shaoli Chaudhuri, MD, MPH, Raaka Kumbhakar, MD, and Ellen Morrison, MD, MPH Heightened privacy and confidentiality stakes generate unique anonymity and nondisclosure policies and practices for HIV. AMA J Ethics. 2021;23(5):E376-381. doi: 10.1001/amajethics.2021.376. Case and Commentary Jun 2021 Trauma-Informed Caring for Native American Patients and Communities Prioritizes Healing, Not Management Michael J. Oldani, PhD, MS and Deidre Prosen, MFA, MS Clinicians must express humility, understand local culture, collaborate, and develop an insider’s perspective on past and present life. AMA J Ethics. 2021;23(6):E446-455. doi: 10.1001/amajethics.2021.446. Case and Commentary Jun 2021 How Should Clinicians Help Patients Navigate “Model Minority” Demands? Nellie Tran, PhD, Kevin Yabes, MS, and Arianne Miller, PhD The model minority myth has far-reaching implications for Asian Americans in many settings, including medicine. AMA J Ethics. 2021;23(6):E456-464. doi: 10.1001/amajethics.2021.456. Case and Commentary Jun 2021 How Should Clinicians Respond to Children in Transgenerationally Traumatized Families? Diego Chaves-Gnecco, MD, MPH Pediatricians have obligations to find causes of children’s stress and respond with care to their clinical and social vulnerabilities. AMA J Ethics. 2021;23(6):E465-470. doi: 10.1001/amajethics.2021.465. Medicine and Society Jun 2021 What Does It Mean to Heal From Historical Trauma? Natalie Avalos, PhD Responding well means navigating ongoing grief, restoring self-community and human-ecological relationships, and generating cultural vibrancy. AMA J Ethics. 2021;23(6):E494-498. doi: 10.1001/amajethics.2021.494. Case and Commentary Jul 2021 A Womanist Approach to Caring for Patients With Empirically Unverifiable Symptoms Annette Madlock Gatison, PhD Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives. AMA J Ethics. 2021;23(7):E519-523. doi: 10.1001/amajethics.2021.519. Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705. Pagination First page « First Previous page ‹ Previous … Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Page 15 … Next page Next › Last page Last »
Case and Commentary Apr 2021 Who Should Implement Force When It’s Needed and How Should It Be Done Compassionately? Matthew Lin, MD Covert medication administration might be as forceful as physical or chemical restraint for patients lacking insight. AMA J Ethics. 2021;23(4):E311-317. doi: 10.1001/amajethics.2021.311.
Case and Commentary May 2021 Should Needlestick Protocols Influence Documentation or Disclosure of a Patient’s HIV Status? Shaoli Chaudhuri, MD, MPH, Raaka Kumbhakar, MD, and Ellen Morrison, MD, MPH Heightened privacy and confidentiality stakes generate unique anonymity and nondisclosure policies and practices for HIV. AMA J Ethics. 2021;23(5):E376-381. doi: 10.1001/amajethics.2021.376.
Case and Commentary Jun 2021 Trauma-Informed Caring for Native American Patients and Communities Prioritizes Healing, Not Management Michael J. Oldani, PhD, MS and Deidre Prosen, MFA, MS Clinicians must express humility, understand local culture, collaborate, and develop an insider’s perspective on past and present life. AMA J Ethics. 2021;23(6):E446-455. doi: 10.1001/amajethics.2021.446.
Case and Commentary Jun 2021 How Should Clinicians Help Patients Navigate “Model Minority” Demands? Nellie Tran, PhD, Kevin Yabes, MS, and Arianne Miller, PhD The model minority myth has far-reaching implications for Asian Americans in many settings, including medicine. AMA J Ethics. 2021;23(6):E456-464. doi: 10.1001/amajethics.2021.456.
Case and Commentary Jun 2021 How Should Clinicians Respond to Children in Transgenerationally Traumatized Families? Diego Chaves-Gnecco, MD, MPH Pediatricians have obligations to find causes of children’s stress and respond with care to their clinical and social vulnerabilities. AMA J Ethics. 2021;23(6):E465-470. doi: 10.1001/amajethics.2021.465.
Medicine and Society Jun 2021 What Does It Mean to Heal From Historical Trauma? Natalie Avalos, PhD Responding well means navigating ongoing grief, restoring self-community and human-ecological relationships, and generating cultural vibrancy. AMA J Ethics. 2021;23(6):E494-498. doi: 10.1001/amajethics.2021.494.
Case and Commentary Jul 2021 A Womanist Approach to Caring for Patients With Empirically Unverifiable Symptoms Annette Madlock Gatison, PhD Hyperfocus on measurability can result in evidentiary overreliance and undervaluation of patients’ experience narratives. AMA J Ethics. 2021;23(7):E519-523. doi: 10.1001/amajethics.2021.519.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.
State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705.